Harry G. Brittain, PhD, FRSC
Consultation is available in all areas of pharmaceutical physics and physical pharmacy, including preformulation, formulation design, and drug substance and drug product characterization.  Special expertise is available in the physical characterization of pharmaceutical solids, in the use of spectroscopy for the study of materials, and in all aspects of the polymorphism of drug substances.  Owing to his considerable experience in areas connected with patent litigation, Dr. Brittain is available to assist legal firms with investigational work, case development, and in the production of appropriate documentation.  He can provide expert testimony in the context of depositions and trials, expert advice and conduct of appropriate experimental work, and in the preparation of expert documentation.
The Center for Pharmaceutical Physics contains an array of instrumentation suitable for research work in the areas of pharmaceutical physics and solid-state spectroscopy:  X-ray powder diffraction, differential scanning calorimetry, polarizing optical microscopy, infrared absorption (attenuated total reflectance) spectroscopy, solid-state UV/VIS absorption spectroscopy, Raman spectroscopy, powder flowability evaluation, determination of kinetic or equilibrium solubility, surface tension, conductivity, and fluorescence excitation or emission spectroscopy.  Library facilities include well in excess of 1000 books dealing with pharmaceutics, pharmaceutical technology, and spectroscopy, as well as complete journal holdings in pharmaceutical sciences and physical chemistry.
Prior to forming the Center for Pharmaceutical Physics, Dr. Brittain was Vice President for Pharmaceutical Development at Discovery Laboratories, Inc., Director of Pharmaceutical Development at Ohmeda Inc., and also led a variety of groups within Bristol-Myers Squibb Co.  Dr. Brittain has held faculty positions at Ferrum College and Seton Hall University, and served as Adjunct Professor at Rutgers University and Lehigh University.  He has authored more than 300 research publications and book chapters, and has presented numerous invited lectures and short courses in pharmaceutics.  He has edited the monographs Physical Characterization of Pharmaceutical Solids, Polymorphism in Pharmaceutical Solids, (two editions), Spectroscopy of Pharmaceutical Solids, and co-edited Preformulation in Solid Dosage Form Development.  Dr. Brittain is an Editor for the Journal of Pharmaceutical Sciences, a member of the editorial boards of Pharmaceutical Development and Technology and AAPS PharmSciTech, Chirality, and the Series Editor for the Profiles of Drug Substances, Excipients, and Related Technology.  Dr. Brittain has been a Teacher-Scholar of the Camille and Henry Dreyfus Foundation, and is a Fellow of the American Association of Pharmaceutical Scientists and of the Royal Society of Chemistry.  He received the AAPS Research Achievement Award in Analysis and Pharmaceutical Quality in 1998. 
Contact Dr. Harry G. Brittain at: hbrittain@centerpharmphysics.com, or write to him at the Center for Pharmaceutical Physics, 10 Charles Road, Milford NJ 08848, USA.  The telephone number of the center is (908)-996-3509.